📰 Adxs News
Adxs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Adxs. Real-time updates on events, politics, business and more.
April 27, 2024
StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Wednesday morning. The firm issued a sell rating on the stock. Ayala Pharmaceuticals Stock Up 0.9 % ADXS stock opened at $0.56 on Wednesday. Ayala Pharmaceuticals has a 12-month low of $0.50 and a 12-month […]
March 10, 2024
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report report published on Thursday. The firm issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reaffirmed a neutral rating on shares of Ayala Pharmaceuticals in a research report on Thursday, November 16th. Get Our Latest Stock Report […]
February 7, 2024
By Chris Wack Immunome shares hit their 52-week high of $25.85 on Wednesday, and are now up 381% in the past 12 months. The stock closed Tuesday's session...
February 6, 2024
Research analysts at StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the stock. Separately, LADENBURG THALM/SH SH reissued a “neutral” rating on shares of Ayala Pharmaceuticals in a report on Thursday, November […]
February 6, 2024
By Chris Wack Immunome shares were up 16% to $19.56 after the company agreed to buy AL102 and related drug candidate AL101 from Ayala Pharmaceuticals. Ayala...
February 6, 2024
ADXS | Complete Ayala Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
January 30, 2024
StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report released on Saturday morning. The brokerage issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reiterated a neutral rating on shares of Ayala Pharmaceuticals in a report on Thursday, November 16th. View Our Latest Report on Ayala […]
January 22, 2024
StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Friday morning. The firm issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reiterated a neutral rating on shares of Ayala Pharmaceuticals in a report on Thursday, November 16th. View Our Latest Report […]
January 6, 2024
StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report issued on Wednesday. The firm issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH restated a neutral rating on shares of Ayala Pharmaceuticals in a research note on Thursday, November 16th. Read Our Latest Stock Analysis on ADXS […]
January 5, 2024
Investment analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock. Separately, LADENBURG THALM/SH SH reissued a “neutral” rating on shares of Ayala Pharmaceuticals in a research note on Thursday, November 16th. Read Our Latest […]